Clinical characteristics according to OSA status
| OSA | HROSA | LROSA | p Value | |
| N | 33 | 34 | 40 | |
| Age (years) | 62.4±8.9 | 53.1±13.8 | 56.3±17.4 | 0.03 |
| Sex (female) | 58% | 56% | 60% | 0.94 |
| BMI (kg/m2) | 36.5±8.1 | 34.1±7.2 | 29.9±7.5 | <0.01 |
| T2DM | 88% | 74% | 68% | 0.12 |
| DM duration (years) | 14.7±12.7 | 15.4±10.3 | 17.8±10.9 | 0.19 |
| Retinopathy | 42% | 32% | 35% | 0.79 |
| Nephropathy | 42% | 18% | 13% | <0.01 |
| Neuropathy | 73% | 53% | 63% | 0.25 |
| CAD | 9% | 6% | 18% | 0.26 |
| CVA | 0% | 6% | 3% | 0.34 |
| HTN | 91% | 82% | 65% | 0.02 |
| SBP (mm Hg) | 137.2±20.8 | 139.6±15.8 | 138.3±3.2 | 0.29 |
| DBP (mm Hg) | 76.6±11.4 | 79.5±10.9 | 76.2±10.24 | 0.40 |
| Number of BP medications | 2.0±1.2 | 1.8±1.2 | 1.5±1.3 | 0.19 |
| HbA1C | 8.0±1.2% | 8.3±1.8% | 7.7±1.4% | 0.44 |
| Number of non-insulin DM medications | 1.0±0.9 | 1.1±0.9 | 0.8±0.9 | 0.37 |
| Insulin therapy | 64% | 88% | 85% | 0.02 |
| Insulin TDD (units/kg) | 0.7±0.5 | 0.9±0.5 | 0.6±0.5 | 0.02 |
Data are presented as means±SD.
BP, blood pressure; BMI, body mass index; CAD, coronary artery disease; CVA, cerebral vascular accident; DBP, diastolic blood pressure; DM, diabetes mellitus; Hb1AC, hemoglobin A1C; HROSA, high risk for OSA; HTN, hypertension; LROSA, low risk for OSA; OSA, obstructive sleep apnea; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus; TDD, total daily dose.